Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Tumor Boards
Colleague Insights
Living Resources
Conferences
Nursing Perspectives
Video Expert Opinion
Sign in
Join now

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Renal Cell Carcinoma. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured
Published in Renal Cell Carcinoma

Expert Opinion / Cases · April 28, 2015

RCC Patient With a History of Multiple Malignancies

Heather Greene MSN, FNP, AOCNP

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Heather Greene MSN, FNP, AOCNP

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Bradley Somer MD

    Bradley G. Somer MD

    Apr 28, 2015

    There are several options available. Depending on performance status, you could consider several options including surgical metastatsectomy vs ablation vs SRS.
  • Heather Greene MSN, FNP, AOCNP

    Heather R Greene MSN, FNP, AOCNP

    Apr 28, 2015

    Once the lesion is treated surgically, would you then consider additional treatment with VEGF-TKI therapy if this is another renal recurrence?

  • Andrew Fintel

    May 05, 2015

    I think that surgical resection of the lesion would be of best benefit as long as he has good lung function and performance status as it will allow for treatment and path. Granted, RCC is most likely as his other two cancers were very early stage. I would offer him pazopanib given its superior side effect profile and also that systemic treatment does improve PFS. Though it is retrospective, there is a recent article posted on Practice update that addresses this entitled "Targeted Therapy After Complete Resection of Metastatic Lesions in mRCC".

  • Nov 16, 2024

    Pending Moderator approval.
    Delete

Further Reading

Recently Updated